NCT04980404 2026-03-30Inqovi Maintenance Therapy in Myeloid NeoplasmsMassachusetts General HospitalPhase 1 Active not recruiting22 enrolled
NCT03404193 2026-03-10Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic SyndromeM.D. Anderson Cancer CenterPhase 2 Terminated235 enrolled
NCT06928662 2025-11-06Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of RelapseFred Hutchinson Cancer CenterPhase 1/2 Recruiting36 enrolled
NCT02921061 2020-03-17Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDSFred Hutchinson Cancer CenterPhase 1/2 Completed28 enrolled 13 charts
NCT00002980 2013-02-15Decitabine in Treating Patients With Melanoma or Other Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed